HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match
- Status
- TERMINATED
- Phase
- PHASE2
Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor Cells
- Status
- TERMINATED
- Phase
- PHASE2
Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)
- Status
- COMPLETED
- Phase
- PHASE2
ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- PHASE2
Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE3
Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
T-Cell Depleted Double UCB for Refractory AML
- Status
- TERMINATED
- Phase
- PHASE2
Modified White Blood Cells That Secrete IL-2 and Express a Protein That Targets the ESO-1tumor Protein for Metastatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial
- Status
- TERMINATED
- Phase
- PHASE3
Treatment of Relapsed or Refractory Acute Myeloblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Reduced Intensity Double Umbilical Cord Blood Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG
- Status
- COMPLETED
- Phase
- PHASE2
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Intensified Rituimab Prephase Before FCR in Untreated B-CLL
- Status
- COMPLETED
- Phase
- PHASE2